Zoetis Inc. Debt Securities, Available-for-sale
Zoetis Inc. (ZTS) had Debt Securities, Available-for-sale of $101.00 million as of 2019-12-31, per its 10-K filed 2020-02-13.
Discontinued › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2020-02-13
- 2019-12-31: Debt Securities, Available-for-sale $101.00M.
- 2019-09-30: Debt Securities, Available-for-sale $12.00M.
- 2019-06-30: Debt Securities, Available-for-sale $25.00M.
- 2019-03-31: Debt Securities, Available-for-sale $65.00M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2019-12-31 | $101.00M 10-K · filed 2020-02-13 |
| 2019-09-30 | $12.00M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $25.00M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $65.00M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $101.00M 10-Q · filed 2019-11-07 |
| 2018-09-30 | $118.00M 10-Q · filed 2018-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |